Filtered By:
Condition: Hives
This page shows you your search results in order of relevance. This is page number 9.
Order by Relevance | Date
Total 3976 results found since Jan 2013.
Management of Allergic Patients During the COVID-19 Pandemic in Asia.
We report this consensus to support allergists and clinical immunologists to make optimal decisions under the urgent situation in Asia.
PMID: 32638559 [PubMed]
Source: Allergy, Asthma and Immunology Research - July 10, 2020 Category: Allergy & Immunology Tags: Allergy Asthma Immunol Res Source Type: research
No difference in omalizumab efficacy in patients with asthma by number of asthma-related/allergic comorbidities.
CONCLUSION: In these analyses of placebo-controlled/single-armed studies, on-study exacerbation rates/FEV1 improvements with omalizumab treatment were similar irrespective of comorbidity burden.
PMID: 33465457 [PubMed - as supplied by publisher]
Source: Annals of Allergy, Asthma and Immunology - January 16, 2021 Category: Allergy & Immunology Authors: Chen M, Choo E, Yoo B, Raut P, Haselkorn T, Pazwash H, Holweg CTJ, Hudes G Tags: Ann Allergy Asthma Immunol Source Type: research
The use of LAD2 cells in the mast cell activation test (MAT): a potential tool for food allergy diagnosis
The diagnosis of allergic disease has traditionally relied on clinical history, levels of allergen specific IgE, skin prick tests and for food allergy oral food challenge (OFC). This latter test is considered the gold standard for diagnosis of food allergy and involves the ingestion of gradually increasing amounts of food under medical supervision. During the test, symptoms can range from hives to severe anaphylaxis and this imparts stress in the patient and care provider. The basophil activation test (BAT) and mast cell activation test (MAT) have been proposed as an alternative to OFC but has logistic challenges as the ce...
Source: Journal of Allergy and Clinical Immunology - February 1, 2021 Category: Allergy & Immunology Authors: Mohammad Farazuddin, Nicholas Ludka, James Baker Source Type: research
Strategies for choosing a biologic for your patient with allergy or asthma
CONCLUSION: The numerous biologic options have made the selection of the best biologic for each patient a potential conundrum for clinicians. Adequate point of care biomarkers to facilitate personalized medical therapy are generally lacking. Furthermore, although clinically effective and generally safe, none of the biologics discussed in this review have induced long-standing disease remission. Nevertheless, these agents have given us the opportunity to treat the most severe patients and to better understand the biology of respiratory and allergic diseases. As knowledgeable physicians, we should embrace and be educated on ...
Source: Annals of Allergy, Asthma and Immunology - October 13, 2021 Category: Allergy & Immunology Authors: Tara Saco Israel C Ugalde Juan Carlos Cardet Thomas B Casale Source Type: research
Profile of Urticaria in an Inner-city Pediatric Emergency Department (ED) and its Correlation with Food Allergy
Urticaria may be the first and only presenting sign of a food allergy. Literature reveals that blacks have a higher burden of food allergy when compared to their white counterparts. We aimed to determine factors associated with Pediatric ED visits for urticaria in a hospital serving a black population.
Source: Journal of Allergy and Clinical Immunology - February 1, 2023 Category: Allergy & Immunology Authors: Vrinda Kumar, Caroline Basta, Maria-Anna Vastardi Source Type: research
Autoantibodies in chronic idiopathic urticaria and nonurticarial systemic autoimmune disorders.
CONCLUSION: The CU Index values were elevated in patients with CU and SLE. The presence of these autoantibodies did not correlate with disease activity or presence of thyroid antibodies. Functional autoantibodies may not be specific for chronic idiopathic urticaria, and their role in nonurticarial systemic autoimmune diseases requires further investigation.
PMID: 23244655 [PubMed - in process]
Source: Annals of Allergy, Asthma and Immunology - January 1, 2013 Category: Allergy & Immunology Authors: Cho CB, Stutes SA, Altrich ML, Ardoin SP, Phillips G, Ogbogu PU Tags: Ann Allergy Asthma Immunol Source Type: research
Prolonged hypogammaglobulinemia after adjuvant rituximab for Hodgkin's lymphoma presenting with refractory urticaria.
PMID: 23176893 [PubMed - in process]
Source: Annals of Allergy, Asthma and Immunology - December 1, 2012 Category: Allergy & Immunology Authors: Wolverton W, McClenathan B Tags: Ann Allergy Asthma Immunol Source Type: research
Evaluation and validation of a bee venom sting challenge performed by a micro-syringe.
CONCLUSION: This preliminary study suggests that the micro-syringe challenge with honeybee venom is feasible and produces results indistinguishable from those of the traditional sting challenge.
PMID: 23176884 [PubMed - in process]
Source: Annals of Allergy, Asthma and Immunology - December 1, 2012 Category: Allergy & Immunology Authors: Cortellini G, Severino M, Francescato E, Turillazzi S, Spadolini I, Rogkakou A, Passalacqua G Tags: Ann Allergy Asthma Immunol Source Type: research
Success with immunomodulatory therapies in the treatment of recalcitrant chronic urticaria.
PMID: 23352536 [PubMed - in process]
Source: Annals of Allergy, Asthma and Immunology - January 30, 2013 Category: Allergy & Immunology Authors: Pongonis RM, Fahrenholz JM Tags: Ann Allergy Asthma Immunol Source Type: research
Long-term efficacy of fixed-dose omalizumab for patients with severe chronic spontaneous urticaria.
CONCLUSION: Omalizumab is an effective treatment for inducing and maintaining long-term remission for patients with severe chronic urticaria. Onset of remission is rapid, although duration is variable, with some patients requiring maintenance treatment. Large-scale randomized trials are necessary to confirm our findings that support the long-term efficacy of anti-IgE therapy for the treatment of this disease.
PMID: 23352531 [PubMed - in process]
Source: Annals of Allergy, Asthma and Immunology - January 30, 2013 Category: Allergy & Immunology Authors: Song CH, Stern S, Giruparajah M, Berlin N, Sussman GL Tags: Ann Allergy Asthma Immunol Source Type: research
Prevention of nonsteroidal inflammatory drug-induced urticaria and/or angioedema.
CONCLUSION: Treatment with NSAIDs at normal doses is possible and well tolerated in patients who have experienced NSAID-induced U/AE, which could be prevented by the concomitant use of antihistamines and leukotriene antagonists.
PMID: 23535090 [PubMed - in process]
Source: Annals of Allergy, Asthma and Immunology - April 1, 2013 Category: Allergy & Immunology Authors: Nosbaum A, Braire-Bourrel M, Dubost R, Faudel A, Parat S, Nicolas JF, Bérard F Tags: Ann Allergy Asthma Immunol Source Type: research
Contemporary approaches to the diagnosis and management of physical urticaria.
PMID: 24054356 [PubMed - in process]
Source: Annals of Allergy, Asthma and Immunology - September 25, 2013 Category: Allergy & Immunology Authors: Lang DM, Hsieh FH, Bernstein JA Tags: Ann Allergy Asthma Immunol Source Type: research
Allergy to bee stings could be a protective mechanism
Allergy to the venom in bee stings may be an immune response that prepares the body to withstand a potentially fatal dose of the poison, according to new research from Stanford University School of Medicine. For most people, a bee sting results in some temporary pain and discomfort. But a small minority have a severe allergic reaction known as anaphylactic shock, which includes a drop in blood pressure, itchy hives and breathing problems, and can cause death if not treated straight away...
Source: Health News from Medical News Today - October 25, 2013 Category: Consumer Health News Tags: Allergy Source Type: news
Occupational rhinitis, asthma, and contact urticaria caused by hydrolyzed wheat protein in hairdressers.
PMID: 24267377 [PubMed - in process]
Source: Annals of Allergy, Asthma and Immunology - November 29, 2013 Category: Allergy & Immunology Authors: Airaksinen L, Pallasaho P, Voutilainen R, Pesonen M Tags: Ann Allergy Asthma Immunol Source Type: research
